Ind-Swift
Ticker >

Ind-Swift share price

Ind-Swift Ltd.

NSE: INDSWFTLTD BSE: 524652 SECTOR: Pharmaceuticals & Drugs  16k   17   1

21.32
0 0
BSE: 19 Apr 04:01 PM

Price Summary

Today's High

₹ 21.89

Today's Low

₹ 21.32

52 Week High

₹ 31.09

52 Week Low

₹ 7.75

FinStar

Ownership Below Par
Stock price may face volatility due to ownership structure.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyPoor
The company seems highly inefficient in case of asset management.
FinancialsWeak
Watch out! The company might not be able to sustain any adverse condition.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

₹ 115.48 Cr.

Enterprise Value

₹ 1094.77 Cr.

No. of Shares

5.42 Cr.

P/E

3.88

P/B

0

Face Value

₹ 2

Div. Yield

0 %

Book Value (TTM)

₹  -134.41

CASH

₹ 13.33 Cr.

DEBT

₹ 992.62 Cr.

Promoter Holding

55.58 %

EPS (TTM)

₹  5.5

Sales Growth

3.33%

ROE

0 %

ROCE

28.45%

Profit Growth

230.05 %

Add Your Ratio

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.

PE Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

PB Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year3.33%
3 Year7.64%
5 Year8.78%

Profit Growth

1 Year230.05%
3 Year49.8%
5 Year19.93%

ROE%

1 Year0%
3 Year0%
5 Year0%

ROCE %

1 Year28.45%
3 Year15.77%
5 Year11.3%

Debt/Equity

-1.4086

Price to Cash Flow

1.58

Interest Cover Ratio

1.4356760863163

CFO/PAT (5 Yr. Avg.)

0

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Dec 2023 55.58 42.81
Sep 2023 55.58 42.81
Jun 2023 55.58 42.81
Mar 2023 55.58 42.81
Dec 2022 55.58 42.81
Investors List
* Figures given above are % of equity capital

 Strengths

  • Company’s PEG ratio is 0.0168523610191024.
  • The company has an efficient Cash Conversion Cycle of -212.704009431709 days.
  • The company has a strong degree of Operating leverage, Average Operating leverage stands at 15.6540806722677.

 Limitations

  • The company has shown a poor revenue growth of 7.63948718998884% for the Past 3 years.
  • Company has a poor ROE of 0% over the past 3 years.
  • The company has negative book value.
  • Promoter pledging is high as 42.81%.

Quarterly Result (All Figures in Cr.)

PARTICULARS Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
Net Sales 106.59 105.88 148.54 115.92 102.56
Total Expenditure 88.69 97.93 130.14 104.78 98.07
Operating Profit 17.89 7.95 18.4 11.14 4.49
Other Income 3.2 6.28 5.63 3.15 2.62
Interest 14.84 14.48 14.95 18.27 15.3
Depreciation 7.29 7.24 6.72 6.73 6.78
Exceptional Items 0 60.58 0 0 0
Profit Before Tax -1.03 53.1 2.36 -10.71 -14.97
Tax 0 0 0 0 0
Profit After Tax -1.03 53.1 2.36 -10.71 -14.97
Adjusted EPS (Rs) -0.19 9.8 0.44 -1.98 -2.76

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Net Sales 289.03 329.52 356.06 397.71 410.96
Total Expenditure 278.28 306.18 314.68 352.36 368.93
Operating Profit 10.75 23.34 41.37 45.35 42.03
Other Income 8.44 22.38 15.22 23.55 11.85
Interest 3.77 35.19 52.18 57.16 59.76
Depreciation 33.97 33.59 32.7 32.07 28.67
Exceptional Items 26.74 6.4 -1.21 0.73 60.58
Profit Before Tax 8.19 -16.66 -29.49 -19.6 26.04
Tax 0 2.46 0.32 0.42 0
Net Profit 8.19 -19.12 -29.82 -20.02 26.04
Adjusted EPS (Rs.) 1.51 -3.53 -5.5 -3.7 4.81

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Equity and Liabilities
Share Capital 10.83 10.83 10.83 10.83 10.83
Total Reserves -687.57 -723.95 -706 -731.15 -715.53
Borrowings 644.67 644.21 644.17 619.3 403.11
Other N/C liabilities 14.62 16.42 16.41 14.76 14.47
Current liabilities 615.87 654.13 706.16 718.03 936.33
Total Liabilities 598.42 601.65 671.57 631.76 649.21
Assets
Net Block 290.56 269.66 244.01 235.5 216.46
Capital WIP 0 0 13.06 9 29.73
Intangible WIP 0 0 0 0 0
Investments 41.26 24.06 70.31 64.35 53.73
Loans & Advances 73.09 79.27 79.02 80.46 75.9
Other N/C Assets 0 0 0 0 0
Current Assets 193.51 228.65 265.17 242.44 273.38
Total Assets 598.42 601.65 671.57 631.76 649.21
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Profit from operations 8.19 -19.12 -28.29 -20.34 -34.54
Adjustment 21.32 52.68 88.12 77.94 85.23
Changes in Assets & Liabilities 13.27 1.03 23.68 -6.98 22.36
Tax Paid 0 0 -0.32 -0.42 0
Operating Cash Flow 42.79 34.6 83.19 50.2 73.05
Investing Cash Flow -13.71 -11.35 -16.71 -18.42 -29.35
Financing Cash Flow -13.03 -26.2 -54.25 -44.6 -46.56
Net Cash Flow 16.05 -2.96 12.23 -12.81 -2.85

Corporate Actions

Investors Details

PARTICULARS Dec 2022% Mar 2023% Jun 2023% Sep 2023% Dec 2023%
promoters 55.58 55.58 55.58 55.58 55.58
annie mehta 0.29 0.29 0.29 0.29 0.29
bhanavi mehta 0.06 0.06 0.06 0.06 0.06
deepti munjal 0.06 0.06 0.06 0.06 0.06
divya munjal 0.03 0.03 0.03 0.03 0.03
essix biosciences limited... 31.45 31.45 31.45 31.45 31.45
gopal munjal 3.61 3.61 3.61 3.61 3.61
himanshu jain 0.91 0.91 0.91 0.91 0.91
ishav mehta 0.08 0.08 0.08 0.08 0.08
meenakshi mehta 0.74 0.74 0.74 0.74 0.74
n.r. munjal 1.13 1.13 1.13 1.13 1.13
neera mehta 2.86 2.86 2.86 2.86 2.86
neeta munjal 1.07 1.07 1.07 1.07 1.07
nidhi munjal 0.93 0.93 0.93 0.93 0.93
ravi mehta 1.17 1.17 1.17 1.17 1.17
rishav mehta 0.21 0.21 0.21 0.21 0.21
s. r. mehta 3.76 3.76 3.76 3.76 3.76
sahil munjal 0.24 0.24 0.24 0.24 0.24
saurabh munjal 0.10 0.10 0.10 0.10 0.10
sunita jain 3.35 3.35 3.35 3.35 3.35
v.r. mehta 3.55 3.55 3.55 3.55 3.55
PARTICULARS Dec 2022% Mar 2023% Jun 2023% Sep 2023% Dec 2023%
investors 44.42 44.42 44.42 44.42 44.42
excel motors private limi... 1.08 1.08 1.08 1.08 1.08
gravity systems private l... 1.38 1.38 1.38 1.38 1.38
investor education and pr... 0.90 - - 0.90 0.90
justin pharmaceuticals pr... 1.59 1.59 1.59 1.59 1.59
panchkula finvest private... 1.31 1.31 1.31 1.31 1.31
rameshkumar javerchand ja... 1.67 1.69 1.76 1.77 1.77
sharwan singh guleria 2.05 1.92 1.94 1.94 1.93
deepa ram kheria 1.60 1.60 1.57 1.57 -
investor education and pr... - 0.90 0.90 - -

Annual Reports

Ratings & Research Reports

No Credit and Research reports exist for this company.Report us

Company Presentations

Currently we do not have any Presentation and Concall related to this company.Report us

Ind-Swift Stock Price Analysis and Quick Research Report. Is Ind-Swift an attractive stock to invest in?

 

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into Ind-Swift and its performance over the period of time.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Ind-Swift cash from the operating activity was Rs 73.0459 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Ind-Swift has a Debt to Equity ratio of -1.4086 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Ind-Swift , the EPS growth was 230.052486337319 % which is good for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Ind-Swift has OPM of 10.2281155464884 % which is a bad sign for profitability.
     
  • ROE: Ind-Swift have a poor ROE of 0 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
     
  • Share Price: - The current share price of Ind-Swift is Rs 21.35. One can use valuation calculators of ticker to know if Ind-Swift share price is undervalued or overvalued.
Last Updated on:
Brief about Ind-Swift
X